Assessment of non-steroidal anti-inflammatory and analgesic pharmaceuticals in seawaters of North of Portugal: Occurrence and environmental risk

Science of the Total Environment

Volumn 508, Issue , 2015, Pages 240-250

  Lolić, Aleksandar ^a,b   Paíga, Paula ^a   Santos, Lúcia H M L M ^a,c   Ramos, Sandra ^a   Correia, Manuela ^a   Delerue Matos, Cristina ^a  

^a INSTITUTO SUPERIOR DE ENGENHARIA DO PORTO   (Portugal)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Analgesics; Environmental risk assessment; Non steroidal anti inflammatory drugs; North of Portugal; Seawater; UHPLC MS MS

Indexed keywords

DRUG PRODUCTS; FISH; METABOLITES; SEAWATER; WATER QUALITY;

ANALGESICS; ENVIRONMENTAL RISK ASSESSMENT; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PORTUGAL; U-HPLC-MS;

RISK ASSESSMENT;

2 [4 (2 CARBOXYPROPYL)PHENYL]PROPIONIC ACID; ANALGESIC AGENT; DRUG METABOLITE; HYDROXYIBUPROFEN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; UNCLASSIFIED DRUG; SEA WATER; WATER POLLUTANT;

BATHING WATER; DRUG; ENVIRONMENTAL RISK; LIQUID CHROMATOGRAPHY; MARINE ENVIRONMENT; MASS SPECTROMETRY; METABOLITE; RISK ASSESSMENT; SEAWATER; SPATIAL DISTRIBUTION; WATER QUALITY;

ALGA; ARTICLE; DAPHNIA; ECOTOXICITY; ENTEROCOCCUS; ESCHERICHIA COLI; FISH; GEOGRAPHIC DISTRIBUTION; HUMAN IMPACT (ENVIRONMENT); PORTUGAL; RISK ASSESSMENT; SEA POLLUTION; SEASHORE; SEASONAL VARIATION; TEMPORAL ANALYSIS; TROPHIC LEVEL; WATER QUALITY; ANALYSIS; CHEMISTRY; ENVIRONMENTAL MONITORING; WATER POLLUTANT;

PORTUGAL;

ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ENVIRONMENTAL MONITORING; PORTUGAL; RISK ASSESSMENT; SEAWATER; WATER POLLUTANTS, CHEMICAL;

EID: 84913557736     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2014.11.097     Document Type: Article

References (50)

1. APA.Portuguese Environment Agency (accessed in: 30th September 2013). http://www.apambiente.pt/.
2. Araujo L., Troconis Maria E., Espina Maria B., Prieto Avismelsi Persistence of ibuprofen, ketoprofen, diclofenac and clofibric acid in natural waters. J. Environ. Hum. 2014, 1:32-38.
3. Azur M.J., Stuart E.A., Frangakis C., Leaf P.J. Multiple imputation by chained equations: what is it and how does it work?. Int. J. Methods Psychiatr. Res. 2011, 20:40-49.
4. Bay S.M., Vidal-Dorsch D.E., Schlenk D., Kelley K.M., Maruya K.A., Gully J.R. Integrated coastal effects study: synthesis of findings. Environ. Toxicol. Chem. 2012, 31:2711-2722.
5. Bayen S., Zhang H., Desai M.M., Ooi S.K., Kelly B.C. Occurrence and distribution of pharmaceutically active and endocrine disrupting compounds in Singapore's marine environment: influence of hydrodynamics and physical-chemical properties. Environ. Pollut. 2013, 182:1-8.
6. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol. Lett. 2003, 142:185-194.
7. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol. Environ. Saf. 2004, 59:309-315.
8. DeLorenzo M.E., Fleming J. Individual and mixture effects of selected pharmaceuticals and personal care products on the marine phytoplankton species Dunaliella tertiolecta. Arch. Environ. Contam. Toxicol. 2008, 54:203-210.
9. European Comission Technical guidance document on risk assessment in support of Commission Directive 93/67/EEC on risk assessment for new notified substances. Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances, and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. Part II 2003, Institute for Health and Consumer Protection, Italy.
10. European Comission Directive 2006/7/EC of the European Parliament and of the Council of 15 February 2006 concerning the management of bathing water quality and repealing Directive 76/160/EEC. Off. J. Europ. Union 2006, L64:37-51.
11. European Comission Directive 2008/56/EC of the European Parliament and of the Council of 17 June 2008 establishing a framework for community action in the field of marine environmental policy (Marine Strategy Framework Directive). Off. J. Europ. Union 2008, L164:19-40.
12. European Comission Directive 2013/39/EU of 12 August 2013 amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy. Directive 2013/39/EU. Off. J. Europ. Union 2013, L226:1-17.
13. Fang T.-H., Nan F.-H., Chin T.-S., Feng H.-M. The occurrence and distribution of pharmaceutical compounds in the effluents of a major sewage treatment plant in Northern Taiwan and the receiving coastal waters. Mar. Pollut. Bull. 2012, 64:1435-1444.
14. Farré Ml, Pérez S., Kantiani L., Barceló D. Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment. TrAC Trends Anal. Chem. 2008, 27:991-1007.
15. Ferrando-Climent L., Collado N., Buttiglieri G., Gros M., Rodriguez-Roda I., Rodriguez-Mozaz S., Barcelo D. Comprehensive study of ibuprofen and its metabolites in activated sludge batch experiments and aquatic environment. Sci. Total Environ. 2012, 438:404-413.
16. Ginebreda A., Muñoz I., López de Alda M., Brix R., López-Doval J., Barceló D. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Environ. Int. 2010, 36:153-162.
17. Gonçalves C.M.O., Sousa M.A.D., Alpendurada M.F.P.S. Analysis of acidic, basic and neutral pharmaceuticals in river waters: clean-up by 1 degrees, 2 degrees amino anion exchange and enrichment using an hydrophilic adsorbent. Int. J. Environ. Anal. Chem. 2013, 93:1-22.
18. Gros M., Petrovic M., Barceló D. Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 2006, 70:678-690.
19. Gros M., Rodríguez-Mozaz S., Barceló D. Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J. Chromatogr. A 2012, 1248:104-121.
20. INE Tourism Statistics 2013 (accessed in 20th November 2014). http://www.ine.pt/.
21. INFARMED Estatística do Medicamento 2012, INFARMED.
22. Kunkel U., Radke M. Fate of pharmaceuticals in rivers: deriving a benchmark dataset at favorable attenuation conditions. Water Res. 2012, 46:5551-5565.
23. 2 analysis. Water Res. 2010, 44:2325-2335.
24. Loos R., Carvalho R., Antonio D.C., Cornero S., Locoro G., Tavazzi S., Paracchini B., Ghiani M., Lettieri T., Blaha L., Jarosova B., Voorspoels S., Servaes K., Haglund P., Fick J., Lindberg R.H., Schwesig D., Gawlik B.M. EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents. Water Res. 2013, 47:6475-6487.
25. Loos R., Tavazzi S., Paracchini B., Canuti E., Weissteiner C. Analysis of polar organic contaminants in surface water of the northern Adriatic Sea by solid-phase extraction followed by ultrahigh-pressure liquid chromatography-QTRAP(A (R)) MS using a hybrid triple-quadrupole linear ion trap instrument. Anal. Bioanal. Chem. 2013, 405:5875-5885.
26. Madureira T.V., Barreiro J.C., Rocha M.J., Rocha E., Cass Q.B., Tiritan M.E. Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal). Sci. Total Environ. 2010, 408:5513-5520.
27. Navarro A., Tauler R., Lacorte S., Barcelo D. Occurrence and transport of pesticides and alkylphenols in water samples along the Ebro River Basin. J. Hydrol. 2010, 383:18-29.
28. Nebot C., Gibb S.W., Boyd K.G. Quantification of human pharmaceuticals in water samples by high performance liquid chromatography-tandem mass spectrometry. Anal. Chim. Acta. 2007, 598:87-94.
29. Nödler K., Licha T., Bester K., Sauter M. Development of a multi-residue analytical method, based on liquid chromatography-tandem mass spectrometry, for the simultaneous determination of 46 micro-contaminants in aqueous samples. J. Chromatogr. A 2010, 1217:6511-6521.
30. Paíga P., Santos L.M.L.M., Amorim C., Araújo A., Montenegro M.C.S.M., Pena A., Delerue-Matos C. Pilot monitoring study of ibuprofen in surface waters of north of Portugal. Environ. Sci. Pollut. Res. 2013, 20:2410-2420.
31. Paíga P., Lolić A., Hellebuyck F., Santos L.H.M.L., Correia M., Delerue-Matos C. Development of a SPE-UHPLC-MS/MS methodology for the determination of non-steroidal anti-inflammatory and analgesic pharmaceuticals in seawater. J. Pharm. Biomed. Anal. 2014, (in press). 10.1016/j.jpba.2014.06.017.
32. Quinn B., Gagné F., Blaise C. Evaluation of the acute, chronic and teratogenic effects of a mixture of eleven pharmaceuticals on the cnidarian, Hydra attenuata. Sci. Total Environ. 2009, 407:1072-1079.
33. Rabiet M., Togola A., Brissaud F., Seidel J.L., Budzinski H., Elbaz-Poulichet F. Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment. Environ. Sci. Technol. 2006, 40:5282-5288.
34. Ribeiro C., Tiritan M., Rocha E., Rocha M. Seasonal and spatial distribution of several endocrine-disrupting compounds in the Douro River Estuary, Portugal. Arch. Environ. Contam. Toxicol. 2009, 56:1-11.
35. Rocha M.J., Ribeiro M., Ribeiro C., Couto C., Cruzeiro C., Rocha E. Endocrine disruptors in the Leça River and nearby Porto Coast (NW Portugal): presence of estrogenic compounds and hypoxic conditions. Toxicol. Environ. Chem. 2012, 94:262-274.
36. Rocha M.J., Cruzeiro C., Rocha E. Quantification of 17 endocrine disruptor compounds and their spatial and seasonal distribution in the Iberian Ave River and its coastline. Toxicol. Environ. Chem. 2013, 95:386-399.
37. Rodriguez-Navas C., Bjoerklund E., Bak S.A., Hansen M., Krogh K.A., Maya F., Forteza R., Cerda V. Pollution pathways of pharmaceutical residues in the aquatic environment on the Island of Mallorca, Spain. Arch. Environ. Contam. Toxicol. 2013, 65:56-66.
38. Santos L.H.M.L., Gros M., Rodriguez-Mozaz S., Delerue-Matos C., Pena A., Barceló D., Montenegro M.C.B.S. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci. Total Environ. 2013, 461-462:302-316.
39. Santos L.H.M.L., Paíga P., Araújo A.N., Pena A., Delerue-Matos C., Montenegro M.C.B.S. Development of a simple analytical method for the simultaneous determination of paracetamol, paracetamol-glucuronide and p-aminophenol in river water. J. Chromatogr. B 2013, 930:75-81.
40. Shanmugam G., Sampath S., Selvaraj K.K., Larsson D.G.J., Ramaswamy B.R. Non-steroidal anti-inflammatory drugs in Indian rivers. Environ. Sci. Pollut. Res. 2014, 21:921-931.
41. Straub J.O. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001. Toxicol. Lett. 2002, 131:137-143.
42. Togola A., Budzinski H. Multi-residue analysis of pharmaceutical compounds in aqueous samples. J. Chromatogr. A 2008, 1177:150-158.
43. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment - a review. Sci. Total Environ. 2012, 429:123-155.
44. Vidal-Dorsch D.E., Bay S.M., Maruya K., Snyder S.A., Trenholm R.A., Vanderford B.J. Contaminants of emerging concern in municipal wastewater effluents and marine receiving water. Environ. Toxicol. Chem. 2012, 31:2674-2682.
45. Weigel S., Kuhlmann J., Hühnerfuss H. Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea. Sci. Total Environ. 2002, 295:131-141.
46. Weigel S., Berger U., Jensen E., Kallenborn R., Thoresen H., Hühnerfuss H. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 2004, 56:583-592.
47. Wille K., Noppe H., Verheyden K., Vanden Bussche J., De Wulf E., Van Caeter P., Janssen C.R., De Brabander H.F., Vanhaecke L. Validation and application of an LC-MS/MS method for the simultaneous quantification of 13 pharmaceuticals in seawater. Anal. Bioanal. Chem. 2010, 397:1797-1808.
48. Winkler M., Lawrence J.R., Neu T.R. Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems. Water Res. 2001, 35:3197-3205.
49. Wu J., Qian X., Yang Z., Zhang L. Study on the matrix effect in the determination of selected pharmaceutical residues in seawater by solid-phase extraction and ultra-high-performance liquid chromatography-electrospray ionization low-energy collision-induced dissociation tandem mass spectrometry. J. Chromatogr. A 2010, 1217:1471-1475.
50. Ziylan A., Ince N.H. The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: treatability by conventional and non-conventional processes. J. Hazard. Mater. 2011, 187:24-36.